All Programs

Use the tool below to view all available Global Neurology Academy Series

CME/CE In-Person & Virtual Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
1.50 credits
MinuteCE®
Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
0.75 credits 6 episodes
- Dani Cabral, MD
- Marwan Sabbagh, MD, FAAN
0.75 credits 6 episodes
Amyloid-β Therapies in Practice: Not All Are Created Equal
Amyloid-β Therapies in Practice: Not All Are Created Equal
MinuteCE®
Amyloid-β Therapies in Practice: Not All Are Created Equal
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
NPS Agitation: Evidence and Emerging Mechanisms of Management
NPS Agitation: Evidence and Emerging Mechanisms of Management
MinuteCE®
NPS Agitation: Evidence and Emerging Mechanisms of Management
0.75 program credits
- Dani Cabral, MD
- Mohammed Q. Al-Sabbagh, MD
0.75 program credits
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
NeuroFrontiers
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
- Ryan Quigley
Friedreich’s Ataxia: Impact of Frataxin Loss
Friedreich’s Ataxia: Impact of Frataxin Loss
NeuroFrontiers
Friedreich’s Ataxia: Impact of Frataxin Loss
- Arnulf Koeppen, MD
Is Friedreich’s Ataxia Developmental or Degenerative?
Is Friedreich’s Ataxia Developmental or Degenerative?
NeuroFrontiers
Is Friedreich’s Ataxia Developmental or Degenerative?
- Arnulf Koeppen, MD
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiers
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
- Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
NeuroFrontiers
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
BCMA mRNA CAR-T Shows Durable Benefit in MG
BCMA mRNA CAR-T Shows Durable Benefit in MG
NeuroFrontiers
BCMA mRNA CAR-T Shows Durable Benefit in MG
FA hiPSCs in Translational Drug Development
FA hiPSCs in Translational Drug Development
NeuroFrontiers
FA hiPSCs in Translational Drug Development
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
CME/CE Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
CME/CE In-Person Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida
Proactive Pregnancy Planning and Reproductive Care in MS
Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiers
Proactive Pregnancy Planning and Reproductive Care in MS
- Riley Bove, MD, MMSc
Emerging Serum microRNAs as Early Signals in MS
Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiers
Emerging Serum microRNAs as Early Signals in MS
Addressing Social and Systemic Barriers in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
- Shelina Ramnarine, PhD
- Margaret Emerson, DNP, APRN, PMHNP-BC

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title